Mycobacterium abscessus: a new antibiotic nightmare

Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae

(2011) S. Chopra et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Genetic analysis of new 16S rRNA mutations conferring aminoglycoside resistance in Mycobacterium abscessus

(2011) Rachid Nessar et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs

(2011) Jiwon Lyu et al.   RESPIRATORY MEDICINE

Clinical Significance of Differentiation ofMycobacterium massiliensefromMycobacterium abscessus

(2010) Won-Jung Koh et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Assessment of Clarithromycin Susceptibility in Strains Belonging to theMycobacterium abscessusGroup byerm(41) andrrlSequencing

(2010) Sylvaine Bastian et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Nontuberculous mycobacteria: opportunistic environmental pathogens for predisposed hosts

(2010) J. L. Cook   BRITISH MEDICAL BULLETIN

Clarithromycin and amikacin vs. clarithromycin and moxifloxacin for the treatment of post-acupuncture cutaneous infections due to Mycobacterium abscessus: a prospective observational study

(2010) W.S. Choi et al.   CLINICAL MICROBIOLOGY AND INFECTION

High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria

(2010) Gwan-Han Shen et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Multilocus Sequence Analysis and rpoB Sequencing of Mycobacterium abscessus (Sensu Lato) Strains

(2010) E. Macheras et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis

(2010) Charles R. Esther et al.   Journal of Cystic Fibrosis

Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns

(2010) Hee-Youn Kim et al.   MICROBIOLOGY AND IMMUNOLOGY

Antibiotic Treatment ofMycobacterium abscessusLung Disease

(2009) Kyeongman Jeon et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance

(2009) G. E. Louw et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Role of the Mycobacterium tuberculosis P55 Efflux Pump in Intrinsic Drug Resistance, Oxidative Stress Responses, and Growth

(2009) S. Ramon-Garcia et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae

(2009) K. A. Nash et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

An outbreak of skin and soft tissue infection caused by Mycobacterium abscessus following acupuncture

(2009) S.-J. Koh et al.   CLINICAL MICROBIOLOGY AND INFECTION

Cohort Study of Molecular Identification and Typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii

(2009) A. M. Zelazny et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Inaccuracy of Single-Target Sequencing for Discriminating Species of the Mycobacterium abscessus Group

(2009) E. Macheras et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Characterization of Mycobacteria from a Major Brazilian Outbreak Suggests that Revision of the Taxonomic Status of Members of the Mycobacterium chelonae-M. abscessus Group Is Needed

(2009) S. C. Leao et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Non-tuberculous mycobacteria in children with cystic fibrosis: Isolation, prevalence, and predictors

(2009) Dhenuka K. Radhakrishnan et al.   PEDIATRIC PULMONOLOGY

Non Mycobacterial Virulence Genes in the Genome of the Emerging Pathogen Mycobacterium abscessus

(2009) Fabienne Ripoll et al.   PLoS One

Pulmonary nontuberculous mycobacterial infections: Antibiotic treatment and associated costs

(2009) Guillermo J. Ballarino et al.   RESPIRATORY MEDICINE

Mutagenesis in the  3 4 GyrA Helix and in the Toprim Domain of GyrB Refines the Contribution of Mycobacterium tuberculosis DNA Gyrase to Intrinsic Resistance to Quinolones

(2008) S. Matrat et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular Characterization of Mycobacterium massiliense and Mycobacterium bolletii in Isolates Collected from Outbreaks of Infections after Laparoscopic Surgeries and Cosmetic Procedures

(2008) C. Viana-Niero et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Proportions of Mycobacterium massiliense and Mycobacterium bolletii Strains among Korean Mycobacterium chelonae-Mycobacterium abscessus Group Isolates

(2008) H.-Y. Kim et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In Vitro Antimicrobial Susceptibility of Mycobacterium abscessus in Korea

(2008) Sunghoon Park et al.   JOURNAL OF KOREAN MEDICAL SCIENCE